A novel hybrid delivery system: Polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA)

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 721-731

  Narvekar, Mayuri ^a   Xue, Hui Yi ^a   Wong, Ho Lun ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

All trans retinoic acid; Controlled drug delivery; Lipophilic drug; Nanomedicine; PLGA

Indexed keywords

DRUG CARRIER; INDOMETACIN; POLYGLACTIN; POLYMER OIL NANOSTRUCTURED CARRIER; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ENCAPSULATION; HUMAN; HUMAN CELL; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG STABILITY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; NANOPARTICLES; OILS; POLYGLYCOLIC ACID; TRETINOIN;

EID: 84865281559     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.07.042     Document Type: Article

References (42)

1. W. Abdelwahed, G. Degobert, and H. Fessi Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage Eur. J. Pharm. Biopharm. 63 2006 87 94
2. C.E. Astete, and C.M. Sabliov Synthesis and characterization of PLGA nanoparticles J. Biomater. Sci. Polym. Ed. 17 2006 247 289
3. B.J. Aungst P-glycoprotein secretory transport, and other barriers to the oral delivery of anti-HIV drugs Adv. Drug Deliv. Rev. 39 1999 105 116
4. I. Bala, S. Hariharan, and M.N. Kumar PLGA nanoparticles in drug delivery: the state of the art Crit. Rev. Ther. Drug Carrier Syst. 21 2004 387 422
5. E.R. Balmayor, H.S. Azevedo, and R.L. Reis Controlled delivery systems: from pharmaceuticals to cells and genes Pharm. Res. 28 2011 1241 1258
6. G. Barratt Colloidal drug carriers: achievements and perspectives Cell. Mol. Life Sci. 60 2003 21 37
7. E. Beetge, J. du Plessis, D.G. Müller, C. Goosen, and F.J. van Rensburg The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption Int. J. Pharm. 193 2000 261 264
8. H. Bunjes Lipid nanoparticles for the delivery of poorly water-soluble drugs J. Pharm. Pharmacol. 62 2010 1637 1645
9. Z. Cai, Y. Wang, L.J. Zhu, and Z.Q. Liu Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs Curr. Drug Metab. 11 2010 197 207
10. P. Calvo, J.L. Vila-Jato, and M.J. Alonso Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers J. Pharm. Sci. 85 1996 530 536
11. A. Chinsriwongkul, P. Opanasopit, T. Ngawhirunpat, N. Chareansriwilaiwat, W. Sila-On, and U. Ruktanonchai Physicochemical properties of lipid emulsions formulated with high-load all-trans-retinoic acid PDA J. Pharm. Sci. Technol. 61 2007 461 471
12. A. Chinsriwongkul, P. Opanasopit, T. Ngawhirunpat, T. Rojanarata, W. Sila-On, and U. Ruktanonchai Oleic acid enhances all-trans retinoic acid loading in nano-lipid emulsions PDA J. Pharm. Sci. Technol. 64 2010 113 123
13. A.R. Dixit, S.J. Rajput, and S.G. Patel Preparation and bioavailability assessment of SMEDDS containing valsartan AAPS PharmSciTech 11 2010 314 321
14. A.S. Hasan, M. Socha, A. Lamprecht, F.E. Ghazouani, A. Sapin, M. Hoffman, P. Maincent, and N. Ubrich Effect of the microencapsulation of nanoparticles on the reduction of burst release Int. J. Pharmaceut. 344 2007 53 61
15. G.Y. Hong, Y.I. Jeong, S.J. Lee, E. Lee, J.S. Oh, and H.C. Lee Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma Arch. Pharm. Res. 34 2011 407 417
16. X. Huang, and C.S. Brazel On the importance and mechanisms of burst release in matrix-controlled drug delivery systems J. Control. Release 73 2001 121 136
17. H.S. Kuo, F.N. Hsu, M.C. Chiang, S.C. You, M.C. Chen, M.J. Lo, and H. Lin The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line Chin. J. Physiol. 52 2009 23 30
18. Y. Li, X.R. Qi, Y. Maitani, and T. Nagai PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations Nanotechnology 20 2009 055106
19. S.-J. Lim, M.-K. Lee, and C.-K. Kim Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders J. Control. Release 100 2004 53 61
20. L. Liu, J.B. Berletch, J.G. Green, M.S. Pate, L.G. Andrews, and T.O. Tollefsbol Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation Mol. Cancer Ther. 3 2004 1003 1009
21. Y. Liu, K. Li, J. Pan, B. Liu, and S.-S. Feng Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel Biomaterials 31 2010 330 338
22. J. Lu, M. Liong, S. Sherman, T. Xia, M. Kovochich, A.E. Nel, J.I. Zink, and F. Tamanoi Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells Nanobiotechnology 3 2007 89 95
23. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
24. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131L 155
25. I. Nandi, M. Bari, and H. Joshi Study of isopropyl myristate microemulsion systems containing cyclodextrins to improve the solubility of 2 model hydrophobic drugs AAPS PharmSciTech 4 2003 E10
26. M. Okuno, S. Kojima, R. Matsushima-Nishiwaki, H. Tsurumi, Y. Muto, S.L. Friedman, and H. Moriwaki Retinoids in cancer chemoprevention Curr. Cancer Drug Targets 4 2004 285 298
27. M. Orlandi, B. Mantovani, K. Ammar, E. Avitabile, P. Dal Monte, and G. Bartolini Retinoids and cancer: antitumoral effects of ATRA 9-cis RA and the new retinoid IIF on the HL-60 leukemic cell line Med. Princ. Pract. 12 2003 164 169
28. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
29. J.S. Park, Y.S. Koh, J.Y. Bang, Y.I. Jeong, and J.J. Lee Antitumor effect of all-trans retinoic acid-encapsulated nanoparticles of methoxy poly(ethylene glycol)-conjugated chitosan against CT-26 colon carcinoma in vitro J. Pharm. Sci. 97 2008 4011 4019
30. F. Ravandi Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy Oncology (Williston Park) 25 2011 741 743
31. C. Salvador-Morales, L. Zhang, R. Langer, and O.C. Farokhzad Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups Biomaterials 30 2009 2231 2240
32. R. Singla, and C.H. Lee Effects of glycerol on the in vitro percutaneous absorption of all-trans retinoic acid Pharmaceut. Dev. Technol. 8 2003 229 237
33. S.R. Sirsi, R.C. Schray, M.A. Wheatley, and G.J. Lutz Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides J. Nanobiotechnol. 7 2009 1
34. T. Tadros, P. Izquierdo, J. Esquena, and C. Solans Formation and stability of nano-emulsions Adv. Colloid Interface Sci. 108-109 2004 303 318
35. S.A. Wissing, O. Kayser, and R.H. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
36. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504
37. H.L. Wong, N. Chattopadhyay, X.Y. Wu, and R. Bendayan Nanotechnology applications for improved delivery of antiretroviral drugs to the brain Adv. Drug Deliv. Rev. 62 2010 503 517
38. H.L. Wong, A.M. Rauth, R. Bendayan, J.L. Manias, M. Ramaswamy, Z. Liu, S.Z. Erhan, and X.Y. Wu A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells Pharm. Res. 23 2006 1574 1585
39. H.Y. Xue, and H.L. Wong Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization Biomaterials 32 2011 2662 2672
40. H.Y. Xue, and H.L. Wong Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended targeted and safer siRNA therapy of prostate cancer in an all-in-one manner ACS Nano 5 2011 7034 7047
41. H. Zhang, K. Satyamoorthy, M. Herlyn, and I. Rosdahl All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells - a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution Carcinogenesis 24 2003 185 191
42. L. Zhang, J.M. Chan, F.X. Gu, J.-W. Rhee, A.Z. Wang, A.F. Radovic-Moreno, F. Alexis, R. Langer, and O.C. Farokhzad Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform ACS Nano 2 2008 1696 1702